Cardiology MCQ – Treatment of transthyretin amyloid cardiomyopathy
Cardiology MCQ – Treatment of transthyretin amyloid cardiomyopathy
Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy:
Trastuzumab
Tafamidis
Tranexamic acid
Tamoxifen
Click here for the correct answer
Source: Cardiophile MD - Category: Cardiology Authors: Prof. Dr. Johnson Francis Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs